表紙:トゥレット症候群(TS) - 世界の臨床試験レビュー:2020年前期
市場調査レポート
商品コード
955993

トゥレット症候群(TS) - 世界の臨床試験レビュー:2020年前期

Tourette Syndrome Global Clinical Trials Review, H1, 2020

出版日: | 発行: GlobalData | ページ情報: 英文 | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.18円
トゥレット症候群(TS) - 世界の臨床試験レビュー:2020年前期
出版日: 2020年06月15日
発行: GlobalData
ページ情報: 英文
納期: 即納可能 即納可能とは
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、トゥレット症候群(TS)の臨床試験に関する主要データを提供しており、試験数とその世界の主要諸国で実施された平均登録数、地域、国(G7およびE7)、試験のフェーズ、試験のステータス、エンドポイントのステータス、スポンサータイプ別による疾患の臨床試験の範囲、進行中の試験における有望な薬剤に関する情報も提供しています。

目次

表のリスト

図のリスト

  • レポートガイダンス
  • GlobalData臨床試験レポートのカバレッジ
  • 臨床試験:地域別
  • 臨床試験と平均登録数:国別
  • アジア太平洋において臨床試験に貢献している上位5ヶ国
  • 欧州において臨床試験に貢献している上位5ヶ国
  • 北米において臨床試験に貢献している上位国
  • 中東・アフリカにおいて臨床試験に貢献している上位5ヶ国
  • 中南米において臨床試験に貢献している上位5ヶ国
  • G7諸国における臨床試験:中枢神経系臨床試験に対するトゥレット症候群 (TS) の割合
  • G7諸国における臨床試験:フェーズ別
  • G7諸国における臨床試験:試験ステータス別
  • E7諸国における臨床試験:中枢神経系臨床試験に対するトゥレット症候群 (TS) の割合
  • E7諸国における臨床試験:フェーズ別
  • E7諸国における臨床試験:試験ステータス別
  • 臨床試験:フェーズ別
  • 進行中の臨床試験:フェーズ別
  • 臨床試験:試験ステータス別
  • 臨床試験:エンドポイントステータス別
  • 一定期間募集された被験者
  • 臨床試験:スポンサータイプ別
  • 有望なスポンサー
  • トゥレット症候群 (TS) 治療の臨床試験に参加している上位企業
  • 有望な医薬品
  • 臨床試験プロファイルのスナップショット

付録

  • 略語
  • 定義
  • 調査手法
  • 2次調査
  • GlobalDataについて
  • お問い合わせ
  • ソース
図表

List of Tables

List of Tables

  • Tourette Syndrome Therapeutics, Global, Clinical Trials by Region, 2020*
  • Tourette Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Tourette Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2020*
  • Proportion of Tourette Syndrome to Central Nervous System Clinical Trials, G7 Countries (%), 2020*
  • Tourette Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Tourette Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Tourette Syndrome to Central Nervous System Clinical Trials, E7 Countries (%), 2020*
  • Tourette Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Tourette Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Tourette Syndrome Therapeutics, Global, Clinical Trials by Phase, 2020*
  • Tourette Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2020*
  • Tourette Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Tourette Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*

List of Figures

List of Figures

  • Tourette Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2020*
  • Tourette Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Tourette Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2020*
  • Proportion of Tourette Syndrome to Central Nervous System Clinical Trials, G7 Countries (%), 2020*
  • Tourette Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Tourette Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Tourette Syndrome to Central Nervous System Clinical Trials, E7 Countries (%), 2020*
  • Tourette Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Tourette Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Tourette Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2020*
  • Tourette Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2020*
  • Tourette Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Tourette Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Tourette Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*
  • GlobalData Methodology
目次
Product Code: GDHC6287CTIDB

GlobalData's clinical trial report, "Tourette Syndrome Global Clinical Trials Review, H1, 2020" provides an overview of Tourette Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on Tourette Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

List of Tables

List of Figures

  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Tourette Syndrome to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Tourette Syndrome to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Tourette Syndrome Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots

Appendix

  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About GlobalData
  • Contact Us
  • Source